UBS ETF Please confirm that you are resident in Switzerland to proceed.

Back

UBS ETF (LU) Bloomberg Barclays US Liquid Corporates 1-5 UCITS ETF

Net asset value 13.8416 CHF

Last update

11.09.2019

ISIN: LU1048315755

Asset Class:  Fixed Income

Download all data as XLS File

10 largest constituents

#

Securities

Coupon

Maturity

ISIN

Currency

Price

Weight %

1

CVS HEALTH CORP 3.70000% 18-09.03.23

3.70

09.03.2023

US126650CV07

USD

104.35

2.99

2

BK OF AMERICA CORP 3.004%/VAR 18-20.12.23

3.00

20.12.2023

US06051GHC69

USD

102.40

2.93

3

BROADCOM CORP/CAYMAN FIN LTD 3.00000% 18-15.01.22

3.00

15.01.2022

US11134LAD10

USD

100.80

1.68

4

BRISTOL-MYERS SQUIBB CO-144A 2.90000% 19-26.07.24

2.90

26.07.2024

US110122BZ08

USD

103.60

1.61

5

GOLDMAN SACHS GROUP INC 2.876%/3M LIBOR+82.1BP 17-31.10.22

2.88

31.10.2022

US38148YAC21

USD

101.27

1.57

6

HALFMOON PARENT INC-144A 3.75000% 18-15.07.23

3.75

15.07.2023

US40573LAL09

USD

104.94

1.55

7

WELLS FARGO & CO 3.75000% 19-24.01.24

3.75

24.01.2024

US95000U2C66

USD

106.37

1.52

8

BANK OF AMERICA CORP 3.550%/3M LIBOR+78BP 18-05.03.24

3.55

05.03.2024

US06051GHF90

USD

104.39

1.49

9

CVS HEALTH CORP 3.35000% 18-09.03.21

3.35

09.03.2021

US126650DC17

USD

101.96

1.46

10

WALMART INC 3.40000% 18-26.06.23

3.40

26.06.2023

US931142EK56

USD

105.58

1.39

This overview shows the portfolio positions. The actual positions of the ETF may deviate from this. Source: State Street, 20.08.2019

Composition data

Ticker

CBUS5S SW

Total net assets

151,365,945.51

Total outstanding ETF Shares

10,884,915.00

Base currency

CHF

Source: State Street, 22.08.2019

Disclaimer

For marketing and information purposes by UBS. UBS funds under Luxembourg law. Representative in Switzerland for UBS funds established under foreign law: UBS Fund Management (Switzerland) AG, P.O. Box, CH-4002 Basel. Paying agent: UBS Switzerland AG, Bahnhofstrasse 45, CH-8001 Zurich. Prospectuses, simplified prospectuses or key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available in a language required by the local applicable law free of charge from UBS Asset Management Switzerland AG, c/o UBS AG, Bahnhofstrasse 45, 8001 Zürich, Switzerland or from UBS Fund Management (Switzerland) AG, P.O. Box, CH-4002 Basel. Barclays US Liquid Corporates UCITS, Barclays Euro Area Liquid Corporate 1-5 Year Index, Barclays US Liquid Corporate 1-5 Year Index and Barclays Emerging Markets USD Sovereign & Agency 3% Country Capped Index (the “Barclays Indices”) are trademarks of Barclays Capital or its affiliates and have been licensed for use in connection with UBS Exchange Traded Funds. UBS Exchange Traded Funds based on Barclays Indices are not sponsored or endorsed by Barclays Capital or its affiliates. Neither Barclays Capital nor its affiliates make any representation regarding the advisability of investing in UBS Exchange Traded Funds. Before investing in a product please read the latest prospectus carefully and thoroughly. The fund documentation is available free of charge in English and, where relevant, in one of the local language(s) where the fund is registered. The information and opinions contained in this document have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document. Members of the UBS Group may have a position in and may make a purchase and / or sale of any of the securities or other financial instruments mentioned in this document. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS Asset Management Switzerland AG or a local affiliated company. Source for all data and charts (if not indicated otherwise): UBS Asset Management. More explanations of financial terms can be found at ubs.com/glossary © UBS 2019. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.